ArticleTranslational oncology2024

DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB.

Xuliren Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.